This potential risk for disease transmission would
exist if the jet injector nozzle became contaminated with blood during
an injection and was not properly cleaned and disinfected before
subsequent injections.
http://www.cdc.gov/mmwr/preview/mmwrhtml/00025027.htm
CDC-
MMWR Recommendations and Reports
January 28, 1994 / 43(RR01);1-38General
Recommendations on Immunization Recommendations of the Advisory
Committee on Immunization Practices (ACIP)
The following CDC staff members prepared this report:* John C.
Watson, MD, MPH Charles W. LeBaron, MD Sonja S. Hutchins, MD, MPH
Stephen C. Hadler, MD Walter W. Williams, MD, MPH National Immunization
Program, CDC
Jet Injectors
Jet injectors that use the same nozzle tip to vaccinate more than one
person (multiple-use nozzle jet injectors) have been used worldwide
since 1952 to administer vaccines when many persons must be vaccinated
with the same vaccine within a short time period. These jet injectors
have been generally considered safe and effective for delivering vaccine
if used properly by trained personnel; the safety and efficacy of
vaccine administered by these jet injectors are considered comparable to
vaccine administered by needle and syringe.
The multiple-use nozzle jet injector most widely used in the United
States (Ped-o-Jet) has never been implicated in transmission of
bloodborne diseases. However, the report of an outbreak of hepatitis B
virus (HBV) transmission following use of one type of multiple-use
nozzle jet injector in a weight loss clinic and laboratory studies in
which blood contamination of jet injectors has been simulated have
caused concern that the use of multiple-use nozzle jet injectors may
pose a potential hazard of bloodborne-disease transmission to vaccine
recipients (10). This potential risk for disease transmission would
exist if the jet injector nozzle became contaminated with blood during
an injection and was not properly cleaned and disinfected before
subsequent injections. The potential risk of bloodborne-disease
transmission would be greater when vaccinating persons at increased risk
for bloodborne diseases such as HBV or human immunodeficiency virus
(HIV) infection because of behavioral or other risk factors (11,12).
Multiple-use nozzle jet injectors can be used in certain situations
in which large numbers of persons must be rapidly vaccinated with the
same vaccine, the use of needles and syringes is not practical, and
state and/or local health authorities judge that the public health
benefit from the use of the jet injector outweighs the small potential
risk of bloodborne-disease transmission. This potential risk can be
minimized by training health-care workers before the vaccine campaign on
the proper use of jet injectors and by changing the injector tip or
removing the jet injector from use if there is evidence of contamination
with blood or other body fluid. In addition, mathematical and animal
models suggest that the potential risk for bloodborne-disease
transmission can be substantially reduced by swabbing the stationary
injector tip with alcohol or acetone after each injection. It is
advisable to consult sources experienced in the use of jet injectors
(e.g., state or local health departments) before beginning a vaccination
program in which these injectors will be used. Manufacturer's directions
for use and maintenance of the jet injector devices should be followed
closely. Newer models of jet injectors that employ single-use disposable
nozzle tips should not pose a potential risk of bloodborne disease
transmission if used appropriately.
UPDATE:
Jetgun- New PCNIF Fail Safety Test
-The study ended early
because the protector cap needle-free injector (PCNFI)
failed to prevent contamination in the first batch tested (8.2% failure
rate).
Vaccine. 2008 Mar
4;26(10):1344-52. Epub 2008 Jan 18.
|